Tokyo, Japan

Kenji Yoshikawa

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Semiconductor Technology. Top assignees: Honda Giken Kogyo Kabushiki Kaisha, Daiichi Sankyo Company, Limited, Daiichi Pharmaceutical Co., Ltd.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Yoshikawa. Retrieved from https://idiyas.com/inventor/kenji-yoshikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 274(Granted Patents)


Location History:

  • Wako, JP (1998 - 2002)
  • Kanagawa-ken, JP (2016)
  • Shinagawa-ku, JP (2015 - 2017)
  • Tokyo, JP (2004 - 2024)
  • Chuo-ku, JP (2022 - 2024)

Company Filing History:


Years Active: 1998-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cycloalkane Derivatives
Semiconductor Devices
Static Charge Eliminator
Imidazo Derivatives
Bone Density Analysis
Driving State Monitoring
Ethylenediamine
Inventory Management
Arithmetic Processor
Automotive Technology
21 patents (USPTO):Explore Patents

Kenji Yoshikawa: Pioneering Inventor from Tokyo, Japan

Introduction:

Kenji Yoshikawa is a distinguished inventor hailing from Tokyo, Japan, with a remarkable portfolio of 18 patents to his name. His groundbreaking work in the fields of semiconductor manufacturing and pharmaceuticals has significantly contributed to technological advancements globally.

Latest Patents:

1. Method for manufacturing semiconductor devices: Yoshikawa's innovative method involves forming semiconductor devices in one region of a wafer and cleave initiation portions in another, enhancing yield and manufacturing efficiency.

2. Cycloalkane-1,3-diamine derivative: This patent introduces a compound with an inhibitory action on the interaction between menin and an MLL protein, holding potential in the field of pharmaceuticals.

Career Highlights:

Yoshikawa's professional journey includes stints at renowned companies such as Honda Motor Co., Ltd. and Daiichi Pharmaceutical Co., Ltd.. His expertise and ingenuity have been instrumental in driving forward technological progress in both the automotive and pharmaceutical sectors.

Collaborations:

Throughout his career, Kenji Yoshikawa has collaborated with notable colleagues, including Noriyasu Haginoya and Toshiharu Yoshino. Together, they have spearheaded innovative projects and research initiatives, showcasing the power of teamwork in fostering creativity and breakthrough inventions.

Conclusion:

In summary, Kenji Yoshikawa stands out as a prolific inventor whose contributions to semiconductor manufacturing and pharmaceutical research have left a lasting impact on the industry. His dedication to pushing the boundaries of innovation continues to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…